Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes

Volume: 183, Pages: 109154 - 109154
Published: Jan 1, 2022
Abstract
Monogenic diabetes (MD) represents 5-7% of antibody-negative diabetes cases and is a heterogeneous group of disorders.We used targeted next-generation sequencing (NGS) on Illumina NextSeq 550 platform involving the SureSelect assay to perform genetic and clinical characteristics of a study group of 684 individuals, including 542 patients referred from 12 Polish Diabetes Centers with suspected MD diagnosed between December 2016 and December 2019...
Paper Details
Title
Next- generation sequencing is an effective method for diagnosing patients with different forms of monogenic diabetes
Published Date
Jan 1, 2022
Volume
183
Pages
109154 - 109154
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.